Milk products, dietary patterns and blood pressure management

Journal of the American College of Nutrition

Volumn 28, Issue , 2009, Pages 103S-119S

  Kris Etherton, Penny M ^a   Grieger, Jessica A ^a   Hilpert, Kirsten F ^a   West, Sheila G ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Blood pressure; Calcium; Dairy foods; DASH diet; Hypertension; Magnesium; Milk; Potassium

Indexed keywords

CALCITRIOL; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MAGNESIUM; MILK PROTEIN; PARATHYROID HORMONE; POTASSIUM; TRACE ELEMENT;

BLOOD PRESSURE REGULATION; CALCIUM CELL LEVEL; CALCIUM INTAKE; CALCIUM TRANSPORT; CARDIOVASCULAR RISK; DAIRY PRODUCT; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; HUMAN; HYPERTENSION; MILK; POTASSIUM INTAKE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD PRESSURE; DIET; DIET THERAPY; DRUG EFFECT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DAIRY PRODUCTS; DIET; HUMANS; HYPERTENSION; MICRONUTRIENTS; MILK PROTEINS;

EID: 70349244901     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2009.10719804     Document Type: Article

References (127)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ: Selected major risk factors and global and regional burden of disease. Lancet 360:1347–1360, 2002.
2. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349:1498–1504, 1997.
3. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363–2369, 2003.
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42:1206–1252, 2003.
5. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y: Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:E25–E146, 2008.
6. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Agespecific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913, 2002.
7. Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 153:598–615, 1993.
8. Cutler J, Psaty BM, MacMahon S, Furberg CD: In Laragh JH, Brenner BM, eds. “Hypertension: Pathophysiology, Diagnosis, and Management. Public Health Issues in Hypertension Control: What Has Been Learned from Clinical Trials,” 2nd ed. New York: Raven Press, pp 253–270, 1995.
9. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J: Primary prevention of hypertension: Clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 288:1882–1888, 2002.
10. Allender PS, Cutler JA, Follmann D, Cappuccio FP, Pryer J, Elliott P: Dietary calcium and blood pressure: A meta-analysis of randomized clinical trials. Ann Intern Med 124:825–831, 1996.
11. Birkett NJ: Comments on a meta-analysis of the relation between dietary calcium intake and blood pressure. Am J Epidemiol 148:223–228, Discussion 232–233, 1998.
12. Bucher HC, Cook RJ, Guyatt GH, Lang JD, Cook DJ, Hatala R, Hunt DL: Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA 275:1016–1022, 1996.
13. Cappuccio FP, Elliott P, Allender PS, Pryer J, Follman DA, Cutler JA: Epidemiologic association between dietary calcium intake and blood pressure: A meta-analysis of published data. Am J Epidemiol 142:935–945, 1995.
14. Griffith LE, Guyatt GH, Cook RJ, Bucher HC, Cook DJ: The influence of dietary and nondietary calcium supplementation on blood pressure: An updated metaanalysis of randomized controlled trials. Am J Hypertens 12:84–92, 1999.
15. Hamet P: The evaluation of the scientific evidence for a relationship between calcium and hypertension. J Nutr 125:311S–400S, 1995.
16. Pryer J, Cappuccio FP, Elliott P: Dietary calcium and blood pressure: A review of the observational studies. J Hum Hypertens 9:597–604, 1995.
17. van Mierlo LA, Arends LR, Streppel MT, Zeegers MP, Kok FJ, Grobbee DE, Geleijnse JM: Blood pressure response to calcium supplementation: A meta-analysis of randomized controlled trials. J Hum Hypertens 20:571–580, 2006.
18. Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029, 2007.
19. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR: Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 149:151–161, 1999.
20. Fleming KH, Heimbach JT: Consumption of calcium in the U.S.: Food sources and intake levels. J Nutr 124:1426S–1430S, 1994.
21. U.S. Department of Health and Human Services and U.S. Department of Agriculture: “Dietary Guidelines for Americans.” Washington, DC: Government Printing Office, 2005.
22. United States Department of Agriculture: MyPyramid, 2007.
23. McCarron DA, Morris CD, Henry HJ, Stanton JL: Blood pressure and nutrient intake in the United States. Science 224:1392–1398, 1984.
24. Ackley S, Barrett-Connor E, Suarez L: Dairy products, calcium, and blood pressure. Am J Clin Nutr 38:457–461, 1983.
25. Alonso A, Beunza JJ, Delgado-Rodriguez M, Martinez JA, Martinez-Gonzalez MA: Low-fat dairy consumption and reduced risk of hypertension: The Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr 82:972–979, 2005.
26. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F: Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 82:523–530, 2005.
27. Beydoun MA, Gary TL, Caballero BH, Lawrence RS, Cheskin LJ, Wang Y: Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr 87:1914–1925, 2008.
28. Djousse L, Pankow JS, Hunt SC, Heiss G, Province MA, Kabagambe EK, Ellison RC: Influence of saturated fat and linolenic acid on the association between intake of dairy products and blood pressure. Hypertension 48:335–341, 2006.
29. Elwood PC, Pickering JE, Fehily AM, Hughes J, Ness AR: Milk drinking, ischaemic heart disease and ischaemic stroke I. Evidence from the Caerphilly cohort. Eur J Clin Nutr 58:711–717, 2004.
30. Iso H, Terao A, Kitamura A, Sato S, Naito Y, Kiyama M, Tanigaki M, Iida M, Konishi M, Shimamoto T: Calcium intake and blood pressure in seven Japanese populations. Am J Epidemiol 133:776–783, 1991.
31. Joffres MR, Reed DM, Yano K: Relationship of magnesium intake and other dietary factors to blood pressure: The Honolulu heart study. Am J Clin Nutr 45:469–475, 1987.
32. Pereira MA, Jacobs DR, Jr, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS: Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 287:2081–2089, 2002.
33. Reed D, McGee D, Yano K, Hankin J: Diet, blood pressure, and multicollinearity. Hypertension 7:405–410, 1985.
34. Ruidavets JB, Bongard V, Simon C, Dallongeville J, Ducimetiere P, Arveiler D, Amouyel P, Bingham A, Ferrieres J: Independent contribution of dairy products and calcium intake to blood pressure variations at a population level. J Hypertens 24:671–681, 2006.
35. Steffen LM, Kroenke CH, Yu X, Pereira MA, Slattery ML, Van Horn L, Gross MD, Jacobs DR, Jr: Associations of plant food, dairy product, and meat intakes with 15-y incidence of elevated blood pressure in young black and white adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 82:1169–77; quiz 1363–1364, 2005.
36. Takashima Y, Iwase Y, Yoshida M, Kokaze A, Takagi Y, Taubono Y, Tsugane S, Takahashi T, Iitoi Y, Akabane M, Watanabe S, Akamatsu T: Relationship of food intake and dietary patterns with blood pressure levels among middle-aged Japanese men. J Epidemiol 8:106–115, 1998.
37. Toledo E, Delgado-Rodriguez M, Estruch R, Salas-Salvado J, Corella D, Gomez-Gracia E, Fiol M, Lamuela-Raventos RM, Schroder H, Aros F, Ros E, Ruiz-Gutierrez V, Lapetra J, Conde-Herrera M, Saez G, Vinyoles E, Martinez-Gonzalez MA: Low-fat dairy products and blood pressure: Follow-up of 2290 older persons at high cardiovascular risk participating in the PREDIMED study. Br J Nutr:1–9, 2008.
38. Wang L, Manson JE, Buring JE, Lee IM, Sesso HD: Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 51:1073–1079, 2008.
39. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson J, Witteman J, Stampfer MJ: Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27:1065–1072, 1996.
40. Snijder MB, van Dam RM, Stehouwer CD, Hiddink GJ, Heine RJ, Dekker JM: A prospective study of dairy consumption in relation to changes in metabolic risk factors: The Hoorn Study. Obesity (Silver Spring) 16:706–709, 2008.
41. Snijder MB, van der Heijden AA, van Dam RM, Stehouwer CD, Hiddink GJ, Nijpels G, Heine RJ, Bouter LM, Dekker JM: Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study. Am J Clin Nutr 85:989–995, 2007.
42. Schroder H, Schmelz E, Marrugat J: Relationship between diet and blood pressure in a representative Mediterranean population. Eur J Nutr 41:161–167, 2002.
43. Mizushima S, Cappuccio FP, Nichols R, Elliott P: Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens 12:447–453, 1998.
44. Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ: Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension 31:131–138, 1998.
45. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Metaanalysis of randomized controlled clinical trials. JAMA 277: 1624–1632, 1997.
46. Alonso A, de la Fuente C, Martin-Arnau AM, de Irala J, Martinez JA, Martinez-Gonzalez MA: Fruit and vegetable consumption is inversely associated with blood pressure in a Mediterranean population with a high vegetable-fat intake: The Seguimiento Universidad de Navarra (SUN) Study. Br J Nutr 92:311–319, 2004.
47. John JH, Ziebland S, Yudkin P, Roe LS, Neil HA: Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: A randomised controlled trial. Lancet 359: 1969–1974, 2002.
48. Miura K, Greenland P, Stamler J, Liu K, Daviglus ML, Nakagawa H: Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men: The Chicago Western Electric Study. Am J Epidemiol 159:572–580, 2004.
49. Jorde R, Bonaa KH: Calcium from dairy products, vitamin D intake, and blood pressure: The Tromso Study. Am J Clin Nutr 71:1530–1535, 2000.
50. Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA, Mason J: Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2:CD004639, 2006.
51. Beyer FR, Dickinson HO, Nicolson DJ, Ford GA, Mason J: Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 3:CD004805, 2006.
52. Patki PS, Singh J, Gokhale SV, Bulakh PM, Shrotri DS, Patwardhan B: Efficacy of potassium and magnesium in essential hypertension: A double-blind, placebo controlled, crossover study. BMJ 301:521–523, 1990.
53. Sacks FM, Brown LE, Appel L, Borhani NO, Evans D, Whelton P: Combinations of potassium, calcium, and magnesium supplements in hypertension. Hypertension 26:950–956, 1995.
54. Cappuccio FP, MacGregor GA: Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens 9:465–473, 1991.
55. Barr SI, McCarron DA, Heaney RP, Dawson-Hughes B, Berga SL, Stern JS, Oparil S: Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc 100:810–817, 2000.
56. Bierenbaum ML, Wolf E, Bisgeier G, Maginnis WP: Dietary calcium. A method of lowering blood pressure. Am J Hypertens 1:149S–152S, 1988.
57. Hilary Green J, Richards JK, Bunning RL: Blood pressure responses to high-calcium skim milk and potassium-enriched highcalcium skim milk. J Hypertens 18:1331–1339, 2000.
58. Kynast-Gales SA, Massey LK: Effects of dietary calcium from dairy products on ambulatory blood pressure in hypertensive men. J Am Diet Assoc 92:1497–1501, 1992.
59. Van Beresteijn EC, van Schaik M, Schaafsma G: Milk: does it affect blood pressure? A controlled intervention study. J Intern Med 228:477–482, 1990.
60. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336:1117–1124, 1997.
61. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, 3rd, Simons-Morton DG, Karanja N, Lin PH: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344:3–10, 2001.
62. Bierenbaum ML, Fleischman AI, Raichelson RI: Long term human studies on the lipid effects of oral calcium. Lipids 7:202–206, 1972.
63. Harsha DW, Lin PH, Obarzanek E, Karanja NM, Moore TJ, Caballero B: Dietary Approaches to Stop Hypertension: a summary of study results. DASH Collaborative Research Group. J Am Diet Assoc 99:S35–S39, 1999.
64. The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group. Arch Intern Med 151:1413–1423, 1991.
65. Conlin PR, Chow D, Miller ER, 3rd, Svetkey LP, Lin PH, Harsha DW, Moore TJ, Sacks FM, Appel LJ: The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens 13:949–955, 2000.
66. Svetkey LP, Simons-Morton D, Vollmer WM, Appel LJ, Conlin PR, Ryan DH, Ard J, Kennedy BM: Effects of dietary patterns on blood pressure: Subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 159:285–293, 1999.
67. Nowson CA, Worsley A, Margerison C, Jorna MK, Frame AG, Torres SJ, Godfrey SJ: Blood pressure response to dietary modifications in free-living individuals. J Nutr 134:2322–2329, 2004.
68. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR: Effects of comprehensive lifestyle modification on blood pressure control: Main results of the PREMIER clinical trial. JAMA 289:2083–2093, 2003.
69. Kawano Y, Yoshida K, Kawamura M, Yoshimi H, Ashida T, Abe H, Imanishi M, Kimura G, Kojima S, Kuramochi M: Sodium and noradrenaline in cerebrospinal fluid and blood in salt-sensitive and non-salt-sensitive essential hypertension. Clin Exp Pharmacol Physiol 19:235–241, 1992.
70. Sagnella GA, Markandu ND, Buckley MG, Miller MA, Singer DR, MacGregor GA: Hormonal responses to gradual changes in dietary sodium intake in humans. Am J Physiol 256:R1171–R1175, 1989.
71. Sullivan JM, Ratts TE, Taylor JC, Kraus DH, Barton BR, Patrick DR, Reed SW: Hemodynamic effects of dietary sodium in man: a preliminary report. Hypertension 2:506–514, 1980.
72. Mølstrøm S, Larsen NH, Simonsen JA, Washington R, Bie P: Normotensive sodium loading in normal man: Regulation of renin secretion during beta-receptor blockade. Am J Physiol Regul Integr Comp Physiol 296:R436–R445, 2008.
73. Johnson AG, Nguyen TV, Davis D: Blood pressure is linked to salt intake and modulated by the angiotensinogen gene in normotensive and hypertensive elderly subjects. J Hypertens 19:1053–1060, 2001.
74. Andersen LJ, Norsk P, Johansen LB, Christensen P, Engstrom T, Bie P: Osmoregulatory control of renal sodium excretion after sodium loading in humans. Am J Physiol 275:R1833–R1842, 1998.
75. Rasmussen MS, Simonsen JA, Sandgaard NC, Hoilund-Carlsen PF, Bie P: Mechanisms of acute natriuresis in normal humans on low sodium diet. J Physiol 546:591–603, 2003.
76. Sandgaard NC, Andersen JL, Bie P: Hormonal regulation of renal sodium and water excretion during normotensive sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol 278:R11–R18, 2000.
77. Andersen JL, Andersen LJ, Sandgaard NC, Bie P: Volume expansion natriuresis during servo control of systemic blood pressure in conscious dogs. Am J Physiol Regul Integr Comp Physiol 278:R19–R27, 2000.
78. Bie P, Sandgaard NC: Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol 278:R1–R10, 2000.
79. Squires RD, Huth EJ: Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the renal conservation of potassium. J Clin Invest 38:1134–1148, 1959.
80. Coruzzi P, Brambilla L, Brambilla V, Gualerzi M, Rossi M, Parati G, Di Rienzo M, Tadonio J, Novarini A: Potassium depletion and salt sensitivity in essential hypertension. J Clin Endocrinol Metab 86:2857–2862, 2001.
81. Krishna GG, Chusid P, Hoeldtke RD: Mild potassium depletion provokes renal sodium retention. J Lab Clin Med 109:724–730, 1987.
82. Soleimani M, Bergman JA, Hosford MA, McKinney TD: Potassium depletion increases luminal Na+/H+ exchange and basolateral Na+:CO3+:HCO3+ cotransport in rat renal cortex. J Clin Invest 86:1076–1083, 1990.
83. Blaustein MP: Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol 232:C165–C173, 1977.
84. Young DB, Lin H, McCabe RD: Potassium’s cardiovascular protective mechanisms. Am J Physiol 268:R825–R837, 1995.
85. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA: Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85:679–715, 2005.
86. Morris RC, Jr, Sebastian A, Forman A, Tanaka M, Schmidlin O: Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 33:18–23, 1999.
87. Barden A, Beilin LJ, Vandongen R, Puddey IB: A double-blind placebo-controlled trial of the effects of short-term potassium supplementation on blood pressure and atrial natriuretic peptide in normotensive women. Am J Hypertens 4:206–213, 1991.
88. Zemel M, Gualdoni SM, Walsh MF, Komanicky P, Standley P, Johnson D, Fritter W, Sowers J: Effect of sodium and calcium on calcium metabolism and blood pressure regulation in hypertensive black adults. J Hypertens 4(Suppl 5):364S–366S, 1986.
89. Zemel M, Gualdoni SM, Sowers J: Sodium excretion and plasma renin activity in normotensive and hypertensive black adults as affected by dietary calcium and sodium. J Hypertens 4 (Suppl 5):343S–345S, 1986.
90. Zemel MB, Bedford BA, Standley PR, Sowers JR: Saline infusion causes rapid increase in parathyroid hormone and intracellular calcium levels. Am J Hypertens 2:185–187, 1989.
91. Kabasawa Y, Asahina I, Gunji A, Omura K: Administration of parathyroid hormone, prostaglandin E2, or 1-alpha,25-dihydroxyvitamin D3 restores the bone inductive activity of rhBMP-2 in aged rats. DNA Cell Biol 22:541–546, 2003.
92. Narayanan R, Sepulveda VA, Falzon M, Weigel NL: The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific. J Biol Chem 279:47298–47310, 2004.
93. Bachschmid MM, van der Loo B: A new “sunshine” in the vasculature? Circulation 111:1571–1573, 2005.
94. Shan J, Resnick LM, Lewanczuk RZ, Karpinski E, Li B, Pang PK: 1,25-dihydroxyvitamin D as a cardiovascular hormone. Effects on calcium current and cytosolic free calcium in vascular smooth muscle cells. Am J Hypertens 6:983–988, 1993.
95. Xue H, McCarron DA, Bukoski RD: 1,25 (OH)2 vitamin D3-induced 45CA uptake in vascular myocytes cultured from spontaneously hypertensive and normotensive rats. Life Sci 49:651–659, 1991.
96. Duprez D, de Buyzere M, de Backer T, Clement D: Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension. Blood Press 3:389–393, 1994.
97. Jespersen B, Randlov A, Abrahamsen J, Fogh-Andersen N, Olsen NV, Kanstrup IL: Acute cardiovascular effect of 1,25-dihydroxycholecalciferol in essential hypertension. Am J Hypertens 11:659–666, 1998.
98. Zemel MB, Kraniak J, Standley PR, Sowers JR: Erythrocyte cation metabolism in salt-sensitive hypertensive blacks as affected by dietary sodium and calcium. Am J Hypertens 1:386–392, 1988.
99. Hilpert K, West SG, Bagshaw DM, Fishell V, Barnhart L, Lefevre M, Most MM, Zemel MB, Chow M, Hinderliter AL, Kittleson J, Kris-Etheron PM: Effects of dairy products on intracellular calcium and blood pressure in adults with essential hypertension. J Am Coll Nutr (in press).
100. Bogin E, Massry SG, Levi J, Djaldeti M, Bristol G, Smith J: Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest 69:1017–1025, 1982.
101. Kawashima H: Parathyroid hormone causes a transient rise in intracellular ionized calcium in vascular smooth muscle cells. Biochem Biophys Res Commun 166:709–714, 1990.
102. Gold ME, Buga GM, Wood KS, Byrns RE, Chaudhuri G, Ignarro LJ: Antagonistic modulatory roles of magnesium and calcium on release of endothelium-derived relaxing factor and smooth muscle tone. Circ Res 66:355–366, 1990.
103. Laurant P, Berthelot A: Influence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat. Eur J Pharmacol 258:167–172, 1994.
104. Soltani N, Keshavarz M, Sohanaki H, Zahedi Asl S, Dehpour AR: Relaxatory effect of magnesium on mesenteric vascular beds differs from normal and streptozotocin induced diabetic rats. Eur J Pharmacol 508:177–181, 2005.
105. Das R, Kravtsov GM, Ballard HJ, Kwan CY: L-NAME inhibits Mg(2+)-induced rat aortic relaxation in the absence of endothelium. Br J Pharmacol 128:493–499, 1999.
106. Ko EA, Park WS, Earm YE: Extracellular Mg(2+) blocks endothelin-1-induced contraction through the inhibition of nonselective cation channels in coronary smooth muscle. Pflugers Arch 449:195–204, 2004.
107. Kawasaki T, Delea CS, Bartter FC, Smith H: The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 64:193–198, 1978.
108. Kant AK, Graubard BI, Kumanyika SK: Trends in black-white differentials in dietary intakes of U.S. adults, 1971–2002. Am J Prev Med 32:264–272, 2007.
109. Resnick LM, Muller FB, Laragh JH: Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 105:649–654, 1986.
110. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N: Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 135:1019–1028, 2001.
111. Cross KJ, Huq NL, Palamara JE, Perich JW, Reynolds EC: Physicochemical characterization of casein phosphopeptideamorphous calcium phosphate nanocomplexes. J Biol Chem 280: 15362–15369, 2005.
112. Erba D, Ciappellano S, Testolin G: Effect of the ratio of casein phosphopeptides to calcium (w/w) on passive calcium transport in the distal small intestine of rats. Nutrition 18:743–746, 2002.
113. Meisel H, Bernard H, Fairweather-Tait S, FitzGerald RJ, Hartmann R, Lane CN, McDonagh D, Teucher B, Wal JM: Detection of caseinophosphopeptides in the distal ileostomy fluid of human subjects. Br J Nutr 89:351–359, 2003.
114. De Simone C, Picariello G, Mamone G, Stiuso P, Dicitore A, Vanacore D, Chianese L, Addeo F, Ferranti P: Characterisation and cytomodulatory properties of peptides from Mozzarella di Bufala Campana cheese whey. J Pept Sci 15:251–258, 2009.
115. Mullally MM, Meisel H, FitzGerald RJ: Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol Chem Hoppe Seyler 377:259–260, 1996.
116. Pihlanto-Leppala A, Koskinen P, Piilola K, Tupasela T, Korhonen H: Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J Dairy Res 67:53–64, 2000.
117. Brown NJ, Vaughan DE: Angiotensin-converting enzyme inhibitors. Circulation 97:1411–1420, 1998.
118. Ryhanen E-L, Pihlanto-Leppala A, Pahkala E: A new type of ripened low-fat cheese with bioactive properties. International Dairy Journal 11:441–447, 2001.
119. Meisel H, Goepfert A, Gunter S: ACE-Inhibitory activities in milk products. Milchwissenschaft 52:307–311, 1997.
120. Meisel H, Bockelmann W: Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie Van Leeuwenhoek 76:207–215, 1999.
121. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T: Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78:777–783, 1995.
122. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T: A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64:767–771, 1996.
123. Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, Tochikubo O, Ueshima H: Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens 17:701–706, 2004.
124. Itakura H, Ikemoto S, Terada S, Kondo K: The effect of sour milk on blood pressure in untreated hypertensive and normotensive subjects. Journal of Japanese Society of Clinical Nutrition 23:26–31, 2001.
125. Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA, Geleijnse JM: Lactotripeptides show no effect on human blood pressure: Results from a double-blind randomized controlled trial. Hypertension 51:399–405, 2008.
126. Lee YM, Skurk T, Hennig M, Hauner H: Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr 46:21–27, 2007.
127. Teschemacher H, Koch G, Brantl V: Milk protein-derived opioid receptor ligands. Biopolymers 43:99–117, 1997.